Highbridge Capital Management, LLC 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-25 10:44 am Sale | 2022-12-31 | 13G | CALIDI BIOTHERAPEUTICS, INC. C CLDI | Highbridge Capital Management, LLC | 0 0.000% | -12,154 (Position Closed) | Filing |
| 2022-02-03 08:27 am Purchase | 2021-12-31 | 13G | CALIDI BIOTHERAPEUTICS, INC. C CLDI | Highbridge Capital Management, LLC | 12,154 6.340% | 1,006 (+9.02%) | Filing |